Hyperglycemia, hypertriglyceridemia, and acute pancreatitis in COVID-19 infection: clinical implications

C Gadiparthi, M Bassi, B Yegneswaran, S Ho… - Pancreas, 2020 - journals.lww.com
To the Editor: Coronavirus disease 2019 (COVID-19), an emerging disease of variable
severity caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is …

Type-2 diabetes as a risk factor for severe COVID-19 infection

M Norouzi, S Norouzi, A Ruggiero, MS Khan, S Myers… - Microorganisms, 2021 - mdpi.com
The current outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), termed coronavirus disease 2019 (COVID-19), has generated a notable challenge …

Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients

A Kumar, P Kumar, A Dungdung, AK Gupta… - Diabetes & Metabolic …, 2020 - Elsevier
Background–COVID-19 caused by SARS-CoV-2 leads to myriad range of organ
involvement including liver dysfunction. Aim To analyse the liver function in patients with …

Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients

B Dariya, GP Nagaraju - Cytokine & growth factor reviews, 2020 - Elsevier
The current pandemic outbreak of COVID-19 originated from Wuhan, China. It is caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with significant mortality …